Effect of Individualized Exercise in Elderly Patients With Coronary Heart Disease
Launched by THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIVERSITY · Sep 4, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of personalized exercise programs for older adults with coronary heart disease, which is a condition that affects the heart's blood vessels. The goal is to see how tailored exercise can improve heart health, reduce health problems, and enhance overall quality of life for participants. The trial is currently looking for people aged 60 to 75 who have been diagnosed with coronary heart disease and have a stable heart rhythm.
To participate, individuals must be able to exercise safely, meaning they should not have severe heart or lung issues, serious movement disorders, or uncontrolled health conditions like high blood pressure. If eligible, participants can expect to engage in a customized exercise plan designed to fit their specific health needs. This trial not only aims to help individuals improve their physical health but also to provide support and guidance throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Coronary heart disease: coronary angiography confirmed patients with coronary heart disease.
- • Age is 60-75 years old, and the clinical sinus rhythm is stable.
- • Left ventricular ejection fraction was\> 40%.
- • Informed consent and voluntary participation.
- Exclusion Criteria:
- • Patients with severe organic cardiac and lung diseases.
- • Patients with hemiplegia and other physical action disorders.
- • A history of mental illness.
- • Uncontrolled hypertension, and hemodynamic instability.
- • Severe nephropathy and severe peripheral artery disease.
- • Patients with bone and joint diseases who are not suitable for exercise.
- • Uncontrolled endocrine system and other diseases.
- • Antibiotics and anti-diarrheal medications have not been used for at least 3 months.
About The First Affiliated Hospital With Nanjing Medical University
The First Affiliated Hospital of Nanjing Medical University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital is committed to implementing rigorous scientific methodologies to evaluate new therapies and treatment approaches. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital fosters a collaborative environment aimed at enhancing patient outcomes and contributing to the global medical community. Its strategic focus on translational medicine ensures that groundbreaking discoveries are efficiently translated into practical applications for patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanjing, Jiangsu, China
Patients applied
Trial Officials
Leilei Chen
Study Director
the First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported